WESPAC Advisors SoCal’s Evolus EOLS Stock Holding History

WESPAC Advisors SoCal’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-700	Closed	-$15K	–	152
2019 Q1	$15K	Buy	+700	New	+$15.1K	0.01%	197

Other funds holding EOLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wafra Inc New York $5.95M AUM 6.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WESPAC Advisors SoCal's EOLS Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of Evolus (EOLS) in Q2 2019, closing a stake of 700 shares — an estimated $15K sold.

WESPAC Advisors SoCal first reported a position in EOLS in Q1 2019 and held it in 1 quarter. The position peaked at $15K in Q1 2019. 106 funds tracked by Wall St. Rank hold EOLS as of Q2 2019.

WESPAC Advisors SoCal reported no remaining Evolus position as of Q2 2019 after selling out during the quarter.
WESPAC Advisors SoCal sold 700 Evolus shares in Q2 2019, an estimated $15K.
WESPAC Advisors SoCal first reported a position in Evolus in Q1 2019 and held it in 1 quarter.
WESPAC Advisors SoCal's Evolus position peaked at $15K in Q1 2019.
106 funds tracked by Wall St. Rank held Evolus as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.